Kohjin Bio Co.,Ltd.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 177A |
Chemicals |
Growth |
Nomura |
2024/03/22 |
2024/04/25 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y2,030 |
Total Amount |
Y1,857,250,000 |
| IPO Price |
Y1,900 |
--Company |
Y1,485,800,000 |
Aggregate Value
(based on Initial Price) |
10,180
(Unit:1 million) |
--Leading Shareholder |
Y222,870,000 |
| Listed Shares(total) |
977,500 |
--Lead Manager |
Y148,580,000 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
9.54 |
Offering Price PBR
(based on previous period) |
2.62 |
| 公開価格PER(今期予想ベース) |
27.37 |
| Initial Price PER |
10.19 |
Initial Price PBR |
2.80 |
| New Shares |
850,000 |
Existing Shares |
127,500（only O.A.） |
| Shares Outstanding |
Pre IPO |
4,165,000.00 |
PostIPO |
5,015,000.00 |
| Paid Up Capital |
PreIPO |
Y426,656,000 |
PostIPO |
Y1,169,556,000 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2021/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
3,251,321 |
665,762 |
685,074 |
1,418,904 |
| 2022/03 |
Consolidated |
3,947,089 |
917,837 |
587,675 |
2,216,895 |
| Non-consolidated |
3,622,295 |
841,840 |
564,269 |
2,002,942 |
| 2023/03 |
Consolidated |
4,742,992 |
1,244,391 |
829,790 |
3,017,830 |
| Non-consolidated |
4,406,871 |
1,116,671 |
751,221 |
2,712,308 |
Recent Quarter
2023/12 |
Consolidated |
3,544,575 |
397,839 |
207,138 |
3,184,261 |
| Non-consolidated |
- |
- |
- |
- |
Results Forecast
2024/03 |
Consolidated |
4,724,000 |
560,000 |
289,000 |
- |
| Non-consolidated |
- |
- |
- |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2021/03 |
Consolidated |
10.00 |
- |
- |
|
| Non-consolidated |
202.39 |
412.20 |
|
| 2022/03 |
Consolidated |
10.00 |
173.50 |
532.27 |
|
| Non-consolidated |
166.59 |
480.90 |
|
| 2023/03 |
Consolidated |
19.00 |
199.23 |
724.57 |
|
| Non-consolidated |
180.37 |
651.21 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2023/12 |
Consolidated |
|
49.73 |
- |
|
| Non-consolidated |
- |
- |
|
Results Forecast
2024/03
| Consolidated
| 14.00 |
69.43 |
- |
|
| Non-consolidated |
- |
- |
|
Comment |
| ■Over allotment(127,500)
|
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 90% |
Nomura |
03-3211-1811 |
| 3% |
Mizuho |
03-5208-3210 |
| 3% |
SMBC Nikko |
03-5644-3111 |
| 3% |
Musashi Securities Co.,Ltd |
048-644-0634 |
| 1% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| Data |
| Date of incorporation |
1981/04/20 |
| Company address |
Saitama 350-0214 |
| Telephone |
049-284-3781 |
| President |
|
| Homepage |
https://kohjin-bio.jp/ |
| Auditor |
Azsa |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
53.05% |
| |
10.00% |
| |
6.48% |
| |
4.23% |
| |
3.36% |
| |
2.88% |
| |
2.40% |
| |
2.40% |
| |
2.40% |
| |
1.92% |
| Number of Employees |
133 as of 2024/02/29 |
| Birth Date of Representative |
1949/05/23 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
